Emcure Pharmaceuticals Limited
EMCURE · ISIN: INE168P01015
Constituent of NIFTY 500 TRI (0.03%), NIFTY SC 250 TRI (0.31%)
Earnings (TTM)
CHART
Emcure Pharmaceuticals Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
15.89%
EBITDA Margin (TTM)
53.35
EPS (TTM)
-
EPS Growth (5Y)
-
EPS Growth (10Y)
Technicals
57.39
RSI (14)
1885.82
SMA (50)
1637.87
SMA (200)
17.83
ADX (14)
2048
52-Week High
1260
52-Week Low
41.07%
1Y Return
24.4637
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns